HFE and fatty liver disease: No significant differences in frequencies of the alleles with mutations in coding regions of HFE (C282Y, H63D, and S65C) were detected between the analyzed groups of patients (with stomach cancer, metabolic syndrome, fatty liver disease, or type 2 diabetes mellitus) and the control sample.